Hôpital de la Salpêtrière

To understand the disease mechanisms at work in ALS, our first objective was to perform clinical research and study the natural disease course of ALS. This strategy led to the first successful clinical trial in 1994. Beside our current involvement with clinical trials, we acquired an expertise in muscle biomarkers, genetics and neuroimaging.

Hôpital de la Salpêtrière, Boulevard de l'Hopital, Paris, France


François Salachas

Coordinator and Investigator of research

Dr. François Salachas is Coordinator and Investigator of research in Hôpital Pitié-Salpêtrière.

François Salachas
Current trials
In preparation
Phase iii


Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Read more
Phase iii


Industry trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.
Read more